Dr. Kelly Bolton, M.D.
Claim this profileWashington University School of Medicine
Affiliated Hospitals
Washington University School Of Medicine
Washington University (Data Collection And Specimen Analysis)
Clinical Trials Kelly Bolton, M.D. is currently running
Biomarker-Driven Therapy
for Breast Cancer
This is a prospective study to assess the impact of biomarker driven, early therapeutic switching and delayed imaging with the incorporation of DiviTum® serum TK1 activity ("DiviTum® TKa") in patients with hormone receptor (HR) positive, HER-2 negative metastatic or unresectable breast cancer receiving first-line or second-line treatment.
Recruiting
1 award
N/A
9 criteria
Enasidenib
for Clonal Cytopenia
Study researchers think that a drug called enasidenib may help people with clonal cytopenia of undetermined significance (CCUS) because the drug blocks the mutated IDH2 protein, which may improve blood cell counts. The purpose of this study is to find out whether enasidenib is a safe and effective treatment for CCUS.
Recruiting
1 award
Phase 2
More about Kelly Bolton, M.D.
Clinical Trial Related
2 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 3 Active Clinical Trials
Treatments Kelly Bolton, M.D. has experience with
- Enasidenib
- Ivosidenib
- Ruxolitinib
- CDK4/6 + Endocrine Therapy
- DiviTum® TKa Assay
Breakdown of trials Kelly Bolton, M.D. has run
Clonal Cytopenia
Graft-versus-Host Disease
Breast Cancer
Breast cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Kelly Bolton, M.D. specialize in?
Kelly Bolton, M.D. focuses on Clonal Cytopenia and Graft-versus-Host Disease. In particular, much of their work with Clonal Cytopenia has involved IDH positive patients, or patients who are undergoing treatment.
Is Kelly Bolton, M.D. currently recruiting for clinical trials?
Yes, Kelly Bolton, M.D. is currently recruiting for 3 clinical trials in Saint Louis Missouri. If you're interested in participating, you should apply.
Are there any treatments that Kelly Bolton, M.D. has studied deeply?
Yes, Kelly Bolton, M.D. has studied treatments such as Enasidenib, Ivosidenib, Ruxolitinib.
What is the best way to schedule an appointment with Kelly Bolton, M.D.?
Apply for one of the trials that Kelly Bolton, M.D. is conducting.
What is the office address of Kelly Bolton, M.D.?
The office of Kelly Bolton, M.D. is located at: Washington University School of Medicine, Saint Louis, Missouri 63110 United States. This is the address for their practice at the Washington University School of Medicine.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.